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ABSTRACT 
Some of the most prevalent neurodegenerative 
diseases are characterized by the accumulation of 
amyloid fibrils in organs and tissues. While the 
pathogenic role of these fibrils is not totally 
established, increasing evidences suggest off-
pathway aggregation (OPA) as a source of 
toxic/detoxicating deposits that still remains to be 
targeted. The present work is a step ahead towards 
the development of off-pathway modulators using 
the same amyloid-specific dyes as those 
conventionally employed to screen amyloid 
inhibitors. We identified a series of kinetic 
signatures revealing the quantitative importance of 
OPA relatively to amyloid fibrillization; these 
include non-linear semi-log plots of amyloid 
progress curves, highly variable endpoint signals 
and half-life coordinates weakly influenced by 
concentration. Molecules that attenuate/intensify 
the magnitude of these signals are considered 
promising off-pathway inhibitors/promoters. An 
illustrative example shows that amyloid deposits 
of lysozyme are only the tip of an iceberg hiding a 
crowd of insoluble aggregates. Thoroughly 
validated using advanced microscopy techniques 
and complementary measurements of Dynamic 
Light Scattering (DLS), Circular Dichroism (CD) 
and soluble protein depletion, the new analytical 
tools are compatible with the high-throughput 
methods currently employed in drug discovery. 
 Nucleation and growth mechanisms are 
ubiquitous in nature, from atmospheric aerosol 
formation (1) to microtubule polymerization in 
eukaryotic cells (2) and biomineralization (3). The 
present work focuses amyloid fibril formation as a 
particular case of such phase transition 
phenomena. Amyloid fibrils are filamentous 
assemblies of proteins in which the polypeptide 
backbone is arranged in a characteristic cross--
sheet structure running perpendicular to the long 
axis of the fibrils. Despite the conflicting evidence 
about its pathogenic role (4), the accumulation of 
amyloid deposits in a variety of organs and tissues 
is associated to the most prevalent 
neurodegenerative diseases and to amyloidosis (5). 
Intermediate oligomeric species and off-pathway 
end-products may, however, be more dangerous 
for the development of amyloid diseases than 
mature fibrils themselves (4,6,7,8,9). Conversely, 
the aggregation pathway might be redirected into 
insoluble oligomers less toxic than amyloid fibrils 
(10), given that both types of precipitates 
kinetically compete for soluble protein (11). As 
non-fibrillar species are also hard to detect, the 
molecular mechanisms involved in their formation 
are particularly difficult to infer (12,13,14). Their 
existence should, at any rate, be a disturbance to 
the otherwise predictable sigmoidal to 
hyperbolical kinetics of phase transition. 
 By lacking the cross--sheet structure, 
intermediate and off-pathway species cannot be 
identified using amyloid-specific dyes such as 
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fluorescent thioflavin-T (ThT). If solely amyloid-
like fibrils are produced, the development of the 
mass-of-aggregates signal will be equivalent to the 
depletion of protein monomers in solution (15). 
Both macroscopic indicators should be the result 
of "direct" phase transition events of primary 
(concentration-driven) nucleation, secondary 
(autocatalytic) nucleation and fibril growth (or 
elongation). Other "indirect" events, including 
fibril fragmentation and association, do not 
involve the transition of molecules between phases 
and, therefore, do not affect the reciprocity 
between aggregation of fibrils and depletion of 
protein. Proposed in 2012, the "crystallization-like 
model" (CLM) describes how the molecular 
mechanisms of nucleation and growth affect the 
evolution of amyloid conversion ( ) with time ( t
). The two-parameter CLM equation for unseeded 
reactions reads (16): 
 
 
1
1
1 1a
k t
bk e
  
 
 (1) 
where ak , originally called the growth rate 
constant, is more broadly defined as the 
autocalytic rate constant since it can also include 
the contribution of secondary nucleation steps 
proportional to the amount of amyloid fibrils in 
solution. The parameter bk  gives the relative rates 
of primary nucleation steps over autocatalytic 
steps. Once demonstrated the ability of the CLM 
to describe traditional fibrillization kinetics (16) 
and discriminate between true and apparent 
amyloid inhibitors (17), new CLM-based tools are 
hereby proposed in order to identify off-pathway 
processes. A preliminary note is, however, 
required in order to define what are the regular 
kinetic behaviors expected in the absence of 
parallel aggregation. 
 The current understanding of the kinetics 
and thermodynamics of protein aggregation was 
comprehensively reviewed by Morris, Watzky and 
Finke (18), and more recently, by Gilliam and 
MacPhee (15). The standard sigmoidal growth 
curve exhibiting an initial lag-phase followed by a 
period of rapid growth and a final plateau phase is, 
in general, satisfactorily fitted by the existing 
theoretical models, which gives rise to different 
explanations of the same result. There are, 
however, a number of other common behaviors 
that remain unexplained, even by the more 
sophisticated models (15). Some of these 
inconsistencies are marked in red in Figure 1, 
where a graphical account of typical experimental 
results is also provided. The hyperbolic (concave) 
profiles exhibiting no inflection point or lag-phase 
in absence of seeding (Fig. 1a) are frequently 
reported in literature during the aggregation of 
e.g., serum albumin (19,20), transthyretin (21,22), 
2-microglobulin (23), the four repeat domain of 
Tau (24), apolipoprotein (25) and amyloid- 
variants (26,27). This kind of results is explained 
by the CLM as the result of predominant primary 
nucleation over the autocatalytic processes, and is 
also well fitted by the "Ockham’s Razor" 
minimalistic model (18,28). According to 
Oosawa-type models (29) such as those of Ferrone 
et al. (30) and Knowles et al. (31), the early stage 
increase of the mass of fibrils cannot occur any 
faster than by polynomial nt  or exponential 
 exp kt  laws during unseeded reactions (15,32). 
Therefore, Oosawa-type models fail to explain the 
concave profiles of the form  1 exp kt   shown 
in red in Figure 1a (15). The CLM advantageously 
uses fundamental principles of phase transition to 
explain the nonlinear trends in Figure 1b. By 
expressing the driving force for protein 
aggregation as the thermodynamic supersaturation 
 * *a aC C C    (an approximation to the 
variation in chemical potential), the steady-state 
monomer concentration is expected to correspond 
to the amyloid solubility *aC C  . At the same 
time that the CLM was being proposed, 
Yoshimura et al. urged the need to recognize 
amyloidogenicity as a property determined by the 
monomer concentration relative to solubility (33); 
since then, a wealth of new evidences 
unanimously confirm supersaturation as a major 
driving force for protein aggregation 
(6,11,34,35,36,37,38). Although this parallel with 
crystallization had been hinted before (21,39), the 
common practice in literature models is to assume 
the monomer concentration alone as the driving 
force for phase transition (18,28,29,30,31) 
meaning that, e.g., amyloid fibrils would continue 
to grow until the solution became completely 
depleted from soluble protein. In addition, the 
duration of the lag-phase would be a linear 
function of 0C  when represented in a log-log 
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scale; this follows from model equations of 
variable complexity that, in general, can be 
simplified to a power law equation with a constant 
scaling exponent  (15,40). The same does not 
apply for the CLM, where the lag-times scale 
exponentially with supersaturation 0  rather than 
with the initial concentration 0.C  The result is a 
"broken" curve such as those represented in Figure 
1b, in which the scaling factor  changes its value 
as 0C  decreases to values closer to 
*
aC . Note that 
although the theoretical range of concentrations 
includes the solubility value, the formation of 
fibrils by primary nucleation is only expected to 
occur for 0C  values above a critical concentration 
higher than *.aC  The existence of breaks in lag-
time versus concentration plots is widely reported 
in literature as reviewed by Eden et al. (40). The 
different profiles simulated in Figure 1b result 
from the influence of the initial supersaturation 0  
on the primary nucleation rate constant bk . Both 
ak  and bk  influence the time needed to reach 50% 
completion ( 50t ) as determined by the following 
equation (16): 
 50
1 1
ln 1
a b
t
k k
 
  
 
 (2) 
While the parameter ak  is proportional to 0 , the 
parameter bk  is proportional to the critical number 
of monomers constituting the amyloid nucleus cn , 
whose variation with 0  is not so well established 
(16). Determining the bk  vs. 0  relationship is 
particularly difficult owing to the amplified 
uncertainty associated to bk  estimates when 
sigmoidal aggregation curves are used (16). 
Apparently in contradiction with the Classical 
Nucleation Theory, the value of bk  (and cn ) 
estimated from hyperbolic aggregation kinetics of 
transthyretin is proportional to 0  (16,21). The 
inset in Figure 1b shows how different values of 
0bk   influences the scaling exponent  extracted 
for high monomer concentrations. Sufficiently low 
0bk   values are chosen in order to assure 
meaningful durations of the lag-phase. Although 
other scaling behaviors result from admitting 
different  0bk   functions, the interval of  values 
lying between 2 and 1 is in good agreement 
with recent Monte Carlo simulations that extend 
the classical nucleation-elongation-fragmentation 
scheme to include a stochastic nucleation step 
(40). Each of the closed-form solutions of 
Oosawa-type models predicts a different scaling 
exponent that remains approximately constant 
over the concentration range (15,41); explaining 
the existence of broken curves was shown to 
require additional fundamental insights besides the 
simple interplay between the different mechanistic 
alternatives (40,42). In Ockham’s Razor-type 
models, sigmoidal aggregation curves exhibiting 
pronounced lag-phases correspond to the limit 
case of very low primary nucleation rates for 
which the model equations simplify to a logistic 
function (16). Here again, the exponential factor  
is approximately constant (close to 1) over the 
concentration ranges that produce lag-phases. A 
striking result not covered by any of the scenarios 
in Figure 1b is the weak dependence of the lag-
time on concentration with absolute values of  
well below 1 at high monomer concentrations 
(15,31,40,43). In the case of lysozyme aggregation 
under harsh denaturating conditions the process 
becomes nearly concentration independent ( ≃ 0) 
for protein concentrations significantly higher than 
the solubility (40). The formation of intermediate 
and off-pathway species is a likely explanation of 
this and of other deviations from canonical 
kinetics as illustrated next for HEWL aggregation 
under conditions of low pH (1.6) and high 
temperature (60 ºC) known to produce other 
aggregates than amyloid fibrils (44,45,46). 
 
EXPERIMENTAL PROCEDURES 
Chemicals: HEWL was obtained from Merk 
KGaA (Darmstadt, Germany). ThT was obtained 
from Sigma-Aldrich (St Louis, MO, USA) and 
used as received. Other chemicals were reagent 
grade and obtained from Merk KGaA (Darmstadt, 
Germany). 
HEWL preparation: HEWL powder was dissolved 
in 25 mM HCl pH 1.6 and dialyzed against 25 mM 
HCl, pH 1.6, using a cut-off 3500 Da membrane 
(Spectrum, Fisher Scientific). The concentration of 
the dialyzed protein solution was determined by 
absorbance measurements at 280 nm using an 
extinction coefficient of 37752 M
-1
cm
-1
. Protein 
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tocks were stored at 4 ºC for no longer than one 
week. 
ThT Fluorescence: ThT fluorescence kinetic 
measurements were carried out at 60 ºC in 96-well 
plates (Thermo Scientific, microtiter) in a 
CHAMELEON 
TM
V Microplate Reader (Hidex 
Co., Turku, Finland) at an excitation wavelength 
of 440 nm and an emission wavelength of 485 nm. 
ThT stock solution was prepared by dissolving the 
dried powder in 25 mM HCl, pH 1.6, and filtered 
through a sterile 0.45 μm pore size PES membrane 
filter (Jet Biofil). The concentration was 
determined by absorbance measurements at 411 
nm using an extinction coefficient of 
22000 1 1M cm  . Samples of 120 μl with a final 
ThT concentration of 2.8 mM and HEWL 
concentrations of 0.60, 0.93, 1.25, 1.39 and 1.76 
mM were sealed with 100 μl of paraffin oil. 
Measurements were recorded every 1800 s, after 
sample homogenization by 300s shaking. Data 
was background-corrected for the ThT 
fluorescence of the respective solvent in the 
absence of protein. 
Depletion of soluble HEWL: Independent 1.76 
mM HEWL samples were incubated at 60 ºC and 
periodically filtered through a sterile 0.22 μm pore 
size PES membrane filter (Jet Biofil). After 1 hour 
at room temperature, filtered samples were diluted 
1:50 in 25 mM HCl pH 1.6 and analyzed 
spectrophotometrically at 280 nm using a 1 cm 
pathlength quartz cuvette (Hellma GmbH & Co. 
KG, Müllheim, Germany) and an extinction 
coefficient of 37752 1 1M cm  . 
CD: CD experiments were performed using a 
Jasco J-815 spectropolarimeter (Tokyo, Japan) 
equipped with a Peltier-controlled thermostated 
cell support. Independent 1.76 mM HEWL 
samples were incubated at 60 ºC for periods of 1 
to 7 days. Samples, were diluted 1:400 in 25 mM 
HCl, pH 1.6. CD spectra were measured from 190 
to 260 nm in a 0.1 cm pathlength quartz cuvette 
(Hellma Analytics). The final spectrum of all 
samples was an average of 16 independent scans 
recorded with 1 nm bandwidth, 2 s digital 
integration time and a scanning speed of 50 
nm/min. 
DLS: DLS measurements were performed at 25 ºC 
using an ALV/DLS/ SLS-5000F, SP-86 
goniometer system (ALV-GmbH, Langen, 
Germany) equipped with a CW diode-pumped 
Nd:YAG solid-state Compass-DPSS laser with a 
symmetrizer (Coherent Inc., Santa Clara, CA). The 
laser operates at 532 nm with an output power of 
400 mW. The intensity scale was calibrated 
against scattering from toluene. Independent 1.76 
mM HEWL samples incubated at 60 ºC for 
periods of 1 to 7 days were analyzed at least three 
times. Measurements were made at a scattering 
angle 90º to the incident beam for 5-10 min. 
AFM: Independent 1.76 mM HEWL samples 
incubated at 60 ºC for 0, 1, 2, 3, 4 and 7 days were 
diluted 1:400 in 25 mM HCl, pH 1.6. Samples 
were spin-coated onto silicon wafers and dried in 
vacuum conditions for 4-5 hours. AFM images 
were recorded in non-contact mode using an AFM, 
JEOL instrument (JSPM 4210) equipped with a 
nitride cantilever NSC15 from MicroMasch, USA. 
Typical working frequency and spring constant: 
325 kHz and 40 N/m, respectively. Topography 
images were recorded adapting the offset point 
according to the roughness of each sample. 
TEM: Independent 1.76 mM HEWL samples were 
incubated at 60 ºC for periods of 1 to 7 days. 
Sample solutions were applied onto a carbon–
formvar coated 200–400 mesh spacing grids. After 
1 minute, excess sample solution was removed by 
blotting with filter paper and stained with filtered 
aqueous solution of 2% uranyl acetate (for 45 
seconds). Grids were examined under a JEOL 
JEM 1400 TEM (Tokyo, Japan) operated at 80 kV. 
Images were digitally recorded using a Gatan SC 
1000 ORIUS CCD camera (Warrendale, PA, 
USA). 
Mathematical Model Derivation: In the presence 
of off-pathway aggregation, the increase of total 
aggregates in solution is due to the formation of 
either amyloid fibrils or off-pathway aggregates: 
 
offa
dmdmdm
dt dt dt
   (3) 
While the former process is described by the two-
parameter CLM (16), the latter is here 
characterized by a off-pathway nucleation step, 
which, similar to amyloid nucleation, is considered 
to be second-order in relation to supersaturation: 
 * 2
off
off off
dm
k V
dt
  (4) 
The rate constant *offk  is the nucleation frequency 
expressed per volume of solution (V ). Since the 
two types of aggregates in question have distinct 
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structural organizations, the concentration of 
soluble protein equilibrating the solid phase is also 
different, i.e., supersaturation has to be differently 
defined as a function of the protein solubility *iC  
for amyloid fibrils (subscript i a ) and for off-
pathway aggregates (subscript i off ): 
 
*
*
i
i
i
C C
C


  (5) 
As the formation of total aggregates and the 
depletion of soluble protein are complementary 
processes, m  is proportional to the difference 
 0C C  and i  is alternatively expressed as 
 0,1i i
i
m
M
 
 
  
 
 (6) 
where iM  is the total amount of species i (either a 
or off) that would be produced in the absence of 
the other species (either off or a), and 0,i  is the 
initial supersaturation i evaluated according to eq. 
5  both iM  and 0,i  are proportional to the 
difference  *0 iC C . Accordingly, eq. 4 is 
rewritten as 
 
2
* 2
0, 1
off
off off
off
dm m
k V
dt M

 
   
 
 (7) 
whereas the differential form of the CLM equation 
(16), 
 
0, 0,
d
d
a a a
a b a
a a
k k
t
  

 
 
   
 
 (8) 
is rewritten as 
 
d
1 1
d
a
a b a
a a
m m
k k
t M M


    
        
    
 (9) 
where ak  is defined as the autocalytic rate 
constant and bk  gives the relative rates of primary 
nucleation steps over autocatalytic steps. The 
amyloid conversion is normalized as a a am M   
thus implying that the final value of 1 is only 
reached when no off-pathway aggregates are 
formed. In all other occasions the final value of 
a  represents the fraction of amyloid fibrils 
produced in relation to that expected in the 
absence of a competitive process. In our 
simulations amyloid fibrils are not supposed to 
dissolve once the protein concentration decreases 
below the solubility value *
aC . After that limit, the 
amyloid supersaturation a  is considered 0. By 
adopting normalized units of time ( )ak t   and of 
total amount of aggregates 0( )m M   on eq. 9 
results:  
 0 0
d
1 1
d
a
b a
a a
M M
k
M M

  

    
        
    
 (10)  
The same procedure is applied to eq. 4, which is 
finally replaced in eq. 3 to obtain 
 
0 0
0
2
0
d
1 1
d
1
a
b a
a a
off
off
M M M
k
M M M
M
k
M

  


    
         
    
 
   
 
 (11) 
where offk  is the normalized rate constant for off-
pathway aggregation, 
 
* 2
0,
0
off off
off
a
k V
k
k M

  (12) 
and 0M  is the final amount of total aggregates. 
Being proportional to 0C  minus the final 
concentration of soluble protein (either *aC  or 
*
offC
), 0M  also corresponds to either aM  or offM  
depending on which species  amyloid fibrils or 
off-pathway aggregates  dictates the equilibrium. 
 The system of ordinary differential 
equations formed by eqs. 10 and 11 was solved 
using Matlab subject to the initial conditions 
 0 0a   and  0 0  , and according to the 
details given in each of the following numerical 
simulations. 
Simulation 1Effect of the off-pathway rate 
constant offk  on the aggregation kinetics: We 
have solved eqs. 10 and 11 for different 
combinations of parameters bk  and offk . The used 
value of 0 aM M  was estimated based on 
measurements of *aC  1.50 mM and 
*
offC  0.75 
mM obtained during protein depletion experiments 
carried out at 0C  1.76 mM: 
 
*
00
*
0
off
a a
C CM
M C C



 (13) 
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Since off-pathway aggregates have the lowest 
solubility, the final amount of total aggregates 0M  
is calculated using *offC  as the equilibrium protein 
concentration and 0 1offM M  .  
Simulation 2Effect of the initial protein 
concentration 0C  on the aggregation kinetics: 
Equations 10 and 11 were also solved taking into 
account 0C -dependent variables 0 aM M  (eq. 13), 
bk  (proportional to 0,a ) and offk , whose 
definition can be rewritten as 
 
*
0,
0,
off off
off
w a
k
k
M

 
 
   
 
 (14) 
obtained after replacing in eq. 12 (i) the direct 
dependence of ak  on 0,a , 
 0.a ak   (15) 
and (ii) the definition of 0M , 
  *0 0 off wM C C M V   (16) 
with wM  being the molecular weight of the 
amyloidogenic protein. From the obtained  a   
progress curves we computed the corresponding 
    curves following the definitions given in 
Simulation 1. The theoretical half-life coordinates 
50t  and 50v  were respectively obtained from the 
normalized time required to reach 50% conversion 
50  and from slope d d   at the same instant: 
 5050
0,a
t


  (17) 
 50 0,
50
d
d
av



  (18) 
As arbitrary units of time and aggregation rate are 
used, an arbitrary value of   is also considered. 
The influence of 0C  on 0,a  and 0,off  in eqs. 14, 
17 and 18 is given in eq. 5. Different solutions 
were obtained for different values of 0C , 0,b ak   
and 0, 0,off a offk   . 
 
RESULTS 
The amyloid fibrillization curves of HEWL suggest 
off-pathway aggregation (OPA): The comparative 
analysis made in Introduction indicates that the 
CLM can be used as a touchstone to identify and 
characterize unconventional aggregation kinetics. 
This is now illustrated using in vitro experimental 
data measured by us during the aggregation of 
HEWL under conditions of low pH (1.6), high 
temperature (60 ºC) and high HEWL 
concentration (≥ 0.60 mM) required to produce 
amyloid fibrils without added denaturants or salts. 
Representing the results as the normalized 
intensity of ThT fluorescence with time (Fig. 2a) 
and by the concentration-dependent half-life 
coordinates (Figs. 2b and 2c) does not seem to 
indicate especially unusual kinetics, except the 
weak concentration dependence of 50t  (Fig. 2b) 
and 50v  (Fig. 2c). Characteristic but not exclusive 
of HEWL aggregation, the low reproducibility of 
the results further prevents definitive conclusions 
to be taken without testing wider ranges of protein 
concentrations and numerous other replicates 
(40,43,47,48). The previously reported formation 
of intermediate and off-pathway species during 
amyloid fibrillization of lysozyme should however 
produce atypical kinetic signatures and explain in 
part the poor reproducibility indexes. Parallel 
phase transition processes, such us the formation 
of insoluble oligomers and protein precipitates, 
acts as a sink of the soluble amyloid pool thus 
affecting the rate at which amyloid fibrils are 
formed and their final amount. Since the non-
amyloidogenic pathways also involve stochastic 
nucleation steps, their presence is expected to 
increase the overall variability of the results. 
 The impact of an additional source of 
monomer depletion besides primary nucleation, 
secondary nucleation and fibril elongation was 
investigated within the CLM framework by 
introducing an off-pathway nucleation step, which, 
similar to amyloid nucleation, is considered to be 
second-order in relation to supersaturation. From 
this theoretical exercise, which is described in 
detail in Experimental Procedures, we found 
practical ways to identify supplementary kinetic 
steps from a single aggregation curve (Figs. 3 and 
4); as shown in Figure 3a, the conventional 
hyperbolic/sigmoidal curves previously 
represented in Figure 1a are expected to show a 
noticeable linear phase when amyloid conversion 
is expressed as  1   and represented as a 
function of time in a log-linear scale. Note that 
 1   corresponds to the mass of fibrils 
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already produced divided by the mass of fibrils 
still to be formed. The linear phase starts after 
elapsed a period of time of ≃ 1
ak
  and lasts until 
the end of the reaction. In the case of sigmoidal 
curves (low bk  values in Fig. 3a), this interval 
should include the whole fast growth period. As a 
first fingerprint of the presence of off-pathway 
species, a disturbance to the linear profile is shown 
in Figure 3b with the initial concave phase being 
prolonged until later stages of amyloid fibril 
formation. As the amyloid reaction approaches 
completion, the concave phase is immediately 
succeeded by a convex phase, whose presence 
might be difficult to identify in practice due to the 
increased signal noise of  1   data. As 
Figures 4e and 4f also show, the deviations from 
linearity result from the existence of a parallel 
nucleation step characterized by the rate constant 
offk . Representing the measured HEWL 
aggregation curves in the modified coordinates 
consistently show nonlinear concave trends during 
the fast growth stages - Figure 3c. Owing to 
fluorescence noise amplification, the initial and 
final reaction stages are omitted in Figure 3c. Log-
linear representations of the measured  1   
with the incubation time are a new probe for the 
presence of off-pathway aggregates with facile 
implementation during high-throughput inhibitor 
screenings. However, and as discussed next, the 
information provided by representations such as 
Figure 3c is essentially qualitative and requires 
additional scaling studies in order to be 
consolidated. 
Ideal curves with marked linear phases as in 
Figure 3a do not necessarily mean the absence of 
supplementary pathways, which might take place 
at much slower rates than amyloid fibrillization. 
On the other hand, prolonged concave phases 
eventually followed by a convex phase (Figs. 3b, 
3c, and Figs. 4e and 4f) are a necessary but not 
sufficient condition for the existence of parallel 
phase transition processes, seeing that similar 
outcomes might be produced by other phenomena, 
e.g., fluorescence quenching. The results obtained 
from Simulation 1 (Experimental Procedures) and 
represented in Figures 4a and 4b suggest 
additional evidences based on the variability of the 
endpoint signals F . In principle, these 
thermodynamically determined measurements 
should be highly reproducible since they are not 
subject to stochastic contingencies as, for example, 
the nucleation steps. Figures 4a and 4b show, 
however, that the endpoint signals are expected to 
change as different values of bk  and offk  are 
considered. This is understandable in view of the 
existing competition between amyloid and off-
pathway nucleation: the faster is one process 
relatively to the other, the larger is its share of the 
total soluble protein. In turn, if no OPA takes 
place, it does not matter thermodynamically 
whether amyloid formation is fast or slow, 
reproducible or changeable, because the value of 
F  is mainly determined by the  *0 aC C  
difference. The experimental results previously 
shown in Figure 2a are associated to highly 
variable end-point fluorescence signals (data not 
shown). Such low reproducibility is normally 
associated to the nucleation rate constant bk  due to 
the exponentiation of the lag-time variability (16). 
The propagation of the kinetic uncertainty to the 
F  values can be justified by the occurrence of 
parallel nucleation processes, both characterized 
by fluctuating rate constants ( bk  and offk ). 
OPA Scaling Laws: After having scrutinized the 
progress curves of HEWL aggregation subject to 
different types of normalization and having 
analyzed the variability of the endpoint 
fluorescence signal, it remains to be discussed the 
peculiar scaling laws of 50t  and 50v  with protein 
concentration. In fact, the exponent  determined 
from the results in Figure 2b, and the aggregation 
rate data represented in Figure 2c are indicative of 
abnormally weak influence of 0C  on the two half-
life coordinates. When only amyloid fibrils are 
formed, minimum values of ||≃1 are predicted by 
the CLM under conditions of low nucleation rates 
(Fig. 1b), for which 50v  also reduces to ≃ 4 ak , a 
linear function of 0C  (16). The measured 
relationships shown in Figures 2b and 2C are 
unexpected not only by the 2-parameter CLM as 
by any other current model (see discussion of Fig. 
1). Once again a solution to this problem seems 
possible by extending CLM to account the 
formation of non-amyloidogenic precipitates. The 
altered role of the initial protein concentration is 
studied in Simulation 2 (Experimental 
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Procedures), with Figure 5 showing the numerical 
solutions assuming predominant OPA ( b offk k
≪1). Figure 5a shows that the duration of the lag 
phase hardly changes with the protein 
concentration ( ≃ 0) and that 50t  may even 
increase with 0C  ( > 0). This apparently 
contradictory result is explained by the presence of 
a competitive off-pathway step that is 
comparatively more favored by higher 0C  values 
than the amyloid aggregation step. Equally, Figure 
5b shows that the amyloid aggregation rate 50v  
can be weakly influenced by 0C  or even decrease 
as 0C  increases. To be observed, these paradoxical 
kinetic results require high values of offk  in order 
that the considered range of protein concentration 
is above the critical limit for amyloid formation. 
Figure 5 also shows sudden variations of the 
50 0( )t C  and 50 0( )v C  scaling factors taking place 
along narrow ranges of 0C  values. In agreement 
with estimations of  taken from literature (40), the 
broken curves are not confined to protein 
concentrations close to the amylois solubility (as 
in Fig. 1b) but can be observed for 
*
0 a
C C  values 
≫1. Our selection of bk  and offk  values in 
Figure 5 places the region of weak 0C  
dependencies in the same 
*
0 a
C C  range as that 
used during the HEWL aggregation experiments. 
While reconciling the results of Figures 2b and 2c 
with the theory of protein aggregation, this 
agreement is the first step towards a univocal, all-
inclusive validation of the model of which the 
following section presents a numerical attempt. 
Protein depletion confirms OPA prevalence: At 
this point, we have accumulated a set of evidences 
suggesting that amyloid fibrils are only the tip of 
an iceberg hiding a crowd of ThT-invisible 
aggregates. Although independent from each 
other, these evidences stem, in all cases, from 
conventional ThT fluorescence measurements. 
The first estimations of bk  values ~10
7
, indicate 
that the amyloid nucleation is many order of 
magnitudes slower than the autocatalytic steps. On 
the other hand, offk  values comprised between 
~10
2
 and ~10
1
 configure a case where off-
pathway species are produced at much higher rates 
than amyloid fibrils. These conclusions were 
further tested by complementary techniques, 
namely, by checking whether the depletion of 
protein from solution matches the observed 
kinetics of amyloid fibril formation (Figs. 6a and 
6b). By changing the focus from the amyloid 
fibrils to the dissolved protein we also wanted to 
measure the equilibrium concentration for long 
reaction times as an estimation of the 
thermodynamic solubility. Independent HEWL 
samples incubated at the same conditions of pH 
and temperature as during the fluorimetric assays 
were periodically filtered and analyzed 
spectrophotometrically at 280 nm (see Materials 
and Methods). The results in Figure 6a show that 
solute depletion starts immediately after 
incubation, i.e., before the formation of any 
detectable amount of amyloid fibrils (Fig. 6b); 
moreover, phase transition processes continue to 
occur many days after the plateau in fluorescence 
emission is reached. Besides confirming the 
predominance of OPA, these results also indicate 
that HEWL amyloid fibrils equilibrate with the 
solution earlier, and at higher protein 
concentration, than the other aggregates. The 
simulated curves in Figure 6a were computed 
using the estimates of bk  and offk  that followed 
from ThT fluorescence kinetic analysis and using 
the values of amyloid solubility ( *aC ) and off-
pathway solubility ( *offC ) of 1.50 mM and 0.75 
mM corresponding to estimations of HEWL 
concentration after ~90 h and ≫1000 h incubation, 
respectively. The calculated dimensionless time 
needed to obtain the same total conversion as after 
700 h incubation was 100ak t  , from which the 
value of 1 7ak   h
1
 was determined. The good 
agreement between simulated and measured 
results reported in Figure 6a was achieved using a 
relatively narrow range of offk  values (color bar), 
meaning that the expectable variability of this 
parameter is able to explain the observed 
scattering of the measured profile. Despite all the 
converging evidences, the set of values chosen for 
ak , bk  and offk  should be taken as approximate 
guesses rather than as definitive results. This is 
because the adopted equilibrium concentrations 
for amyloid ( *aC ) and off-pathway (
*
offC ) 
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aggregates are expected to differ substantially 
from the real thermodynamic solubilities. Not only 
the solutions are highly concentrated and nonideal, 
but also the chemical potential of the solute seems 
to be drastically influenced by the presence of 
aggregates in a process akin to volume exclusion 
effects (49). The asymptotic HEWL concentration 
of 0.75 mM estimated for long reaction times 
implies that aggregation assays conducted at 
concentrations below this limit would not produce 
off-pathway precipitates, let alone amyloid fibrils. 
Yet, as the results in Figure 2 demonstrate, HEWL 
concentrations as low as 0.60 mM continue to 
produce aggregates that stain positive for ThT. 
The thermodynamic concentration of dissolved 
protein seems to be decreased by the presence of 
aggregates, which, combined with changes in 
solution viscosity may explain why the phase 
transition processes cease at high HEWL 
concentrations and high content of total 
aggregates. These effects, to be discussed in detail 
elsewhere, imply a faster supersaturation decrease 
than that considered in our model. Therefore, they 
should also account for the differences observed in 
Figure 6b where the measured aggregation curves 
move faster towards equilibrium than the expected 
by the extended CLM for the selected set of 
parameters. Using real protein concentrations in 
our theoretical simulations would require time-
evolving activity coefficients that are not available 
right now. 
Complementary structural, morphological and 
size-distribution data: The changes in the 
secondary structure of HEWL were followed by 
recording the far-UV spectra along the different 
phases of the aggregation process (Fig. 6c). The 
far-UV spectrum of non-incubated HEWL shows 
the 208 nm and 222 nm bands characteristic of the 
α-helical structure of the native protein (50). Upon 
the first day of incubation, the ellipticity strongly 
decreases and the minimum CD intensity takes 
place at slightly lower wavelengths. The same 
tendency is observed until day 4, yet with smaller 
variations of CD. These results indicate the 
formation of pre-amyloid structures, presumably 
amorphous aggregates, which are less helical than 
the initial conformation. The formation of ThT-
positive aggregates after the first day of incubation 
(Fig. 6b) did not provoke the position of minimum 
CD to clearly deviate from ~208 nm to ~215220 
nm as expected for -sheet structures. Therefore, 
and as suggested by the protein depletion results, 
amorphous aggregation seems to prevail over 
amyloid fibrillization since the beginning of 
incubation. The CD intensity continues to decrease 
from day 4 to 7 as a consequence of the formation 
of off-pathway aggregates and the increased 
number and size of scattering objects in solution 
(19). No amyloid fibrils are formed during this 
period as indicated by the ThT fluorescence 
plateau in Figure 6b. 
 To gain insight into the size and 
morphology of the aggregates present in solution, 
samples incubated for different time periods were 
further analyzed using DLS and Atomic Force 
Microscopy (AFM)  Figure 7. The size 
distributions obtained from scattered light 
intensity measurements reveal how the 
populations of soluble protein and insoluble 
aggregates evolve with time (Fig. 7a). The relative 
weight of the peak centered near a hydrodynamic 
radius Rh of 2 nm is an indirect estimate of the 
amount of soluble HEWL. As shown in the inset 
of Figure 7a, the variation of this fraction during 
the incubation time resembles that of protein 
concentration measured by UV absorption in 
Figure 6a. This is another independent verification 
that phase transition processes occur before and 
after amyloid fibril formation. Even though 
particles with Rh greater than 50 nm are identified 
before incubation at 60 C, the first DLS dataset is 
not sufficiently resolved to distinguish between the 
different pre-aggregation species. As the 
incubation starts, the distribution of particles 
centered near 70 nm becomes better defined 
simultaneously with the formation of the 
amorphous aggregates.Coinciding with the period 
of fast ThT fluorescence increase (Fig. 6b), a third 
peak centered near ~500 nm emerges at the end of 
day 2 as the likely result of the formation of 
mature amyloid fibrils. After that, the two 
aggregate peaks become blended in a single 
distribution centered in a hydrodynamic radius still 
close to 100 nm but with the right tail exceeding 
the submicron range. Since the scattering intensity 
of a particle is proportional to the sixth power of 
its diameter, the results in Figure 7a suggest the 
existence of a population of amorphous aggregates 
with mean Rh of 70 nm dominating over a second 
population of greater Rh, presumably mature 
amyloid fibrils, having a widely dispersed size 
distribution owing in part to fibril breakage. Given 
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the limitations of DLS to morphologically describe 
less prevalent, non-spherical particles (51), the 
amyloidogenic samples were also characterized 
using AFM and Transmission Electron 
Microscopy (TEM). The selected AFM image in 
Figure 7b confirms that 1.76 mM HEWL solutions 
at pH 1.6 already contain amorphous aggregates 
before incubation at 60 ºC. Present in all analyzed 
samples, these precipitates generally have the 
shape of a disk with height ~5 nm and diameter 
within the range 20-150 nm also obtained for Rh in 
Figure 7a. Figure 8 shows the results of further 
examinations using TEM, with small worm-like 
aggregates being identified in Figures 8b and 8e. It 
remains unclear whether these protofibrils twist 
over themselves to form disk-shaped aggregates or 
continue to develop to form amyloid fibrils. In 
Figure 7c we surprisingly identified the presence 
of mature amyloid fibrils as long as 2 m and ~10 
nm diameter at the end of the first day of 
incubation. Despite their size, these fibrils are 
scarce enough to remain undetected during ThT 
fluorescence and DLS measurements. Therefore, 
amyloid fibrils seem to grow much faster than they 
are nucleated in agreement with the low value 
estimated for parameter bk  (~10
7
). The AFM 
images in Figures 7d and 7e show well 
differentiated curvilinear fibrils, whereas the TEM 
images additionally report straighter fibrils 
generally surrounded by amorphous aggregates  
see Figures 8e-f. These variations are the likely 
result of different sample handling, which in the 
case of AFM involved 1:400 dilution and spin-
coated deposition onto silicon wafers. 
 
DISCUSSION 
 Similarly to other phase transition 
phenomena, amyloid fibril formation takes place 
via a nucleation and growth mechanism until 
thermodynamic equilibrium is reached. The 
amyloid pathway may however comprise parallel 
steps and intermediate species that are no less 
relevant for the development of amyloidosis and 
neurodegenerative diseases than the deposition of 
fibrils itself. Protein aggregation curves measured 
in vitro using amyloid-specific dyes are shown to 
provide much more information about OPA than 
what is conventionally extracted. The set of 
canonical behaviors summarized in Figure 1 can 
be expected when off-pathway species are either 
absent or present in minor amounts. Even if some 
of those kinetic results are not predicted by 
established theories, they are in conformity with 
the classical mechanism involving primary 
nucleation and auto-catalytic steps. The CLM was 
extended to include a third rate constant ( offk ) 
characterizing the parallel nucleation step. The 
numerical solutions of the three-parameter CLM 
unveil the kinetic signatures characteristic of OPA; 
these include non-linear variation of  1   
with time when plotted in a log-linear scale, highly 
variable endpoint signals, values of the 50t  
absolute scaling factor || below 1 and sublinear 
increase of 50v  with the protein concentration. In 
cases of extensive OPA, increasing the protein 
concentration may even prolong the duration of 
the lag phase and decrease the amyloid 
aggregation rate. This angle of approach is, to our 
knowledge, totally original as the main focus has 
been on the detection and morphological/ 
toxicological characterization of the amorphous 
precipitates (4,7,8,9,14). The new possibility of 
estimating the relative amounts of off-pathway and 
amyloid aggregates accentuates the need for 
cataloguing the deleterious species in each disease. 
After deciding what aspect of protein aggregation 
one wants to target, extensive screenings of off-
pathway modulators can from now on be routinely 
implemented. 
 As a proof-of-concept the modified CLM 
was tested against ThT aggregation data of HEWL 
measured under conditions of low pH (1.6) and 
high temperature (60 ºC) known to produce off-
pathway aggregates. The estimated values of ak , 
bk  and offk  suggest that off-pathway species are 
produced much earlier and at higher rates than 
amyloid fibrils, which, nevertheless, rapidly reach 
their mature size once the stable nucleus is 
formed. This was supported by complementary 
analysis of soluble protein depletion with time, 
far-UV CD spectra, particle size distributions 
measured using DLS and aggregates morphology 
observed using AFM and TEM. We further 
concluded that amorphous aggregates generally 
have the shape of a disk with diameters comprised 
between 20 and 150 nm, even though small worm-
like aggregates were also identified. Amyloid 
fibrils with 10 nm diameter are consistently longer 
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than 1 m and show a broad size distribution as a 
likely consequence of fibril breakage. 
 While offering an explanation for puzzling 
kinetic behaviors, our study contributes to a better 
understanding of the molecular basis of amyloid 
diseases and is expected to find practical 
application in neurodegenerative drug research. By 
using the analytical probes for OPA here 
proposed, libraries of small molecule compounds 
can be screened targeting the formation of 
amorphous aggregates without any additional 
means being required besides the current amyloid-
specific markers and high-throughput methods. 
Whether the kinetic signatures are attenuated or 
intensified by the screened molecules provides a 
valuable indication of their potential as off-
pathway modulators. This therapeutic strategy 
aims at inhibiting or promoting OPA according to 
the disruptive or stabilizing effect that non-fibrillar 
species may have on the regulatory mechanisms 
during disease. 
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FOOTNOTES 
1
From LEPABE, Laboratório de Engenharia de Processos, Ambiente, Biotecnologia e Energia, 
Departamento de Engenharia Química, Faculdade de Engenharia da Universidade do Porto. Rua Dr. 
Roberto Frias, 4200-465 Porto, Portugal 
2
Departamento de Física de la Materia Condensada, Facultad de Física, Universidad de Santiago de 
Compostela, Spain 
3
ICBAS – Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal  
 
The abbreviations used are: AFM, Atomic Force Microscopy; CD, Circular Dichroism; CLM, 
crystallization-like model; DLS, Dynamic Light Scattering; HEWL, hen egg-white lysozyme; OPA, off-
pathway aggregation; SI, Supporting Information; ThT, thioflavin-T; TEM, Transmission Electron 
Microscopy. 
 
FIGURE LEGENDS 
FIGURE 1. Canonical kinetic profiles expected by the CLM (green and red) but not expected by other 
theoretical models (red). (a) Hyperbolic to sigmoidal protein aggregation curves are obtained from Eq. 1 
as the relative magnitude of primary nucleation decreases from 10bk   to 
610  (log-scale color bar). 
Inset: the ak t  timescale is expanded to show complete sigmoidal growth curves. The hyperbolic profiles 
marked in red are not expected for unseeded reactions by Oosawa-type models (29,30,31). (b) log-log 
representation of 50t  (an indicator of the duration of the lag phase) as a function of the protein 
concentration computed using Eq. 2 for different values of 0bk  . The slope of the dashed line 
corresponds to the exponential scaling factor  (illustrative example for high protein concentrations and 
0bk  =10
2
). The broken curves shown in red are not expected by the different closed-form solutions of 
Oosawa-type and Ockham’s Razor-type models. Inset: in the absence of off-pathway processes, the 
absolute value of  is comprised between 1 and 2 according to the value of bk . 
 
FIGURE 2. Influence of the initial protein concentration on the kinetics of amyloid fibril formation of 
HEWL at pH 1.6 and 60 ºC. (a) ThT fluorescence increase during the aggregation of 0.60 mM (blue), 
0.93 mM (light blue), 1.25 mM (green), 1.39 mM (orange) and 1.76 mM (red) HEWL represented in 
normalized units as a function of the incubation time. (b,c) Influence of the initial HEWL concentration 
(b) on the time required to reach 50% completion ( 50t ) and (c) on the aggregation rate at the same instant 
( 50v ). Log-log and linear-linear scales are adopted in (b) and (c), respectively; symbols and error bars 
represent mean values and standard deviations. (b) The linear fit (solid line) indicates an exponential 
scaling factor  of 0.24. 
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FIGURE 3. Kinetic signatures suggesting the presence of off-pathway species. (a) The typical CLM 
aggregation curves in Figure 1 (without OPA) are represented in modified log-linear coordinates relating 
 1   vs. dimensionless time (same color code as in Fig. 1a). Linear relationships are observed for 
1ak t   (after the lag phases in Fig. 1a are surpassed). (b) Effects provoked by other phase transition 
processes besides the nucleation and growth of amyloid fibrils. The linear phase rapidly vanishes in the 
presence of parallel nucleation events characterized by the rate constant offk . Numerical results obtained 
from Simulation 1 (Experimental Procedures), using bk  10
2
 and the values of offk  indicated in the color 
bar. Dashed lines in (a) and (b) correspond to the same result. (c) The measured aggregation curves of 
HEWL in Figure 2a are represented in the modified coordinates (same color code as in Fig. 2a). The 
concave phase prolonged until amyloid conversions close to 1 suggest the existence of OPA. 
 
FIGURE 4. Numerical solutions of the extended CLM accounting off-pathway aggregation. Equation 10
was solved as described in Simulation 1 using bk  10
1
 (left panel) and bk  10
7
 (right panel) and the 
values of offk  given in the right side color bar. Results are expressed as the variation with the normalized 
time ak t  of (A, B) the predicted amyloid fluorescence signal aF F  (equivalent to a ), (C, D) the 
amyloid conversion  , (E, F) the modified amyloid conversion  1   in log-linear scale and (G, H) 
the dimensionless amount of total aggregates 0m M . 
 
FIGURE 5. Influence of the protein concentration on the half-life coordinates when OPA is predominant. 
Solutions of the extended CLM calculated for 60 10bk 
  and given as (a) the log-log representation of 
50t  as a function of the 
*
0 aC C  ratio and (b) the variation of 50v  with 
*
0 aC C . (a,b) Different colors mean 
different 0C -independent offk  values as indicated by the color bar in the right side. Numerical details 
given in Simulation 2 (Experiential Procedures). 
 
FIGURE 6. Complementary data suggesting predominant off-pathway aggregates over amyloid fibrils. 
(a) Symbols: depletion of soluble HEWL at pH 1.6 and 60 ºC with time measured by UV absorption at 
280 nm after filtration through a sterile 0.22 m filter. Lines: protein concentration decrease predicted by 
the extended CLM. (b) Amyloid fibrillization followed by ThT fluorescence (black lines) under the same 
conditions of pH, temperature and initial HEWL concentration (1.76 mM) as in (a). Different colored 
lines: same numerical solution as in (a) expressed as the amyloid content increase with time. HEWL 
depletion in (a) starts before, and continues after the formation of amyloid fibrils in (b). (a,b) Numerical 
results obtained from Simulation 2 (Experiential Procedures), using 1 7ak   h
1
, 710bk
  and the range 
of offk  values indicated by the color bar in the right side; arrows: different instants of time where samples 
were analyzed using CD spectroscopy and DLS. (c) Far-UV CD spectra of HEWL samples incubated for 
0, 1, 2, 3, 4 and 7 days measured at 20ºC and at a 1:400 dilution. Major changes in the CD spectrum occur 
during the first day of incubation and from day 4 to 7, when no measurable amount of new amyloid fibrils 
is formed. 
 
FIGURE 7. Aggregation of 1.76 mM HEWL at pH 1.6 and 60 ºC followed by DLS and AFM. (a) 
Distribution of hydrodynamic radii Rh obtained from DLS measurements at the different instants of time 
marked with an arrow in Figures 6a and 6b. Inset: the relative weight of the soluble HEWL peak centered 
near 2 nm decreases with time. (b-e) Morphology of HEWL aggregates observed with AFM after (b) 0, 
(c) 1, (d) 3 and (e) 4 days incubation; color bar in the right side: height scale common to all AFM images. 
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FIGURE 8. Aggregation of 1.76 mM HEWL at pH 1.6 and 60 ºC followed by Transmission Electron 
Microscopy. (a-c) Amorphous aggregates identified at the end of (a) 1, (b) 2 and (c) 3 days incubation; 
(d-f) amorphous aggregates and amyloid fibrils observed at the end of (d) 2, (e) 3 and (f) 4 days 
incubation. Scale bars represent 200 nm. 
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FIGURES 
Figure 1  
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Figure 2 
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Figure 3 
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Figure 4 
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Figure 5 
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Figure 6 
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Figure 7 
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Figure 8 
 
 at U
N
IV
ERSID
A
D
E D
O
 PO
RTO
 on M
ay 25, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Pedro M. Martins
Rosa Crespo, Eva Villar-Alvarez, Pablo Taboada, Fernando A. Rocha, Ana M. Damas and
What can the kinetics of amyloid fibril formation tell about off-pathway aggregation?
 published online November 24, 2015J. Biol. Chem. 
  
 10.1074/jbc.M115.699348Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
  
 http://www.jbc.org/content/early/2015/11/24/jbc.M115.699348.full.html#ref-list-1
This article cites 0 references, 0 of which can be accessed free at
 at U
N
IV
ERSID
A
D
E D
O
 PO
RTO
 on M
ay 25, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
LEPABE - Laboratory for Process Engineering, Environment, Biotechnology and Energy 
 
 
